Molybdenum cofactor deficiency

Search Trials
Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Status:
Active, not recruiting
Last Changed:
Aug 2, 2017
First Changed:
Jan 1, 1970
Disease(s):
Molybdenum Cofactor Deficiency, Type A
Intervention(s):
ALXN1101
A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Molybdenum Cofactor Deficiency
Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
Status:
Completed
Last Changed:
Jun 11, 2013
First Changed:
Oct 7, 2013
Disease(s):
Molybdenum Cofactor Deficiency (MoCD)
Intervention(s):
ALXN1101Placebo
Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
Status:
Active, not recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Molybdenum Cofactor Deficiency, Type A
Intervention(s):
ALXN1101

Connect. Empower. Inspire.